Ysios Capital
Investor profile
Investment firm
Ysios Capital has backed 20 European tech companies across 25 funding rounds between 2009 and 2026, joining rounds totalling €1.0B. Most active in Healthtech. Data as of Nov 2026.
Deals
25
distinct rounds
Companies
20
backed
Active span
2009–2026
18 yrs
Total round €
€1.0B
sum of rounds joined
Deals by year
distinct rounds / yearYsios Capital — deals by year — interactive chart.
Data table
| Ysios Capital — deals by year | |
|---|---|
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Top sectors
by dealsYsios Capital — top sectors — interactive chart.
Data table
| Ysios Capital — top sectors | |
|---|---|
| Healthtech | 25 |
Stages
by dealsYsios Capital — stages — interactive chart.
Data table
| Ysios Capital — stages | |
|---|---|
| Series C | 7 |
| Series A | 6 |
| Series B | 6 |
| Other | 3 |
| Series D+ | 2 |
| Seed | 1 |
Countries
by dealsYsios Capital — countries — interactive chart.
Data table
| Ysios Capital — countries | |
|---|---|
| Spain | 12 |
| Switzerland | 5 |
| France | 3 |
| Netherlands | 2 |
| Denmark | 1 |
| Sweden | 1 |
| UK | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Gilde Healthcare5
- Asabys Partners4
- Caixa Capital Risc4
- Bpifrance3
- Columbus Venture Partners3
- Kurma Partners3
- Novartis Venture Fund3
- CDTI2
- Edmond de Rothschild Venture Capital2
- Forbion2
- GIMV2
- IDInvest Partners2
- Innogest Capital2
- Jeito Capital2
- M Ventures2
- New Enterprise Associates2
- Novo Seeds2
- Roche Venture Fund2
- Seventure Partners2
- Sofinnova Partners2
- Sunstone Capital2
- UCB Ventures2
- 4BIO Capital1
- Abbvie Biotech Ventures1
- ALSA Ventures1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| SpliceBio | Spain | 2 | €168M |
| Galecto Biotech | Denmark | 1 | €79M |
| Sparingvision | France | 1 | €75M |
| Ona Therapeutics | Spain | 1 | €74M |
| Northsea Therapeutics | Netherlands | 1 | €71M |
| Minoryx Therapeutics | Spain | 2 | €70M |
| Anaconda Biomed | Spain | 2 | €64M |
| ReproNovo | Switzerland | 1 | €57M |
| Endosense | Switzerland | 2 | €56M |
| Xeltis | Switzerland | 1 | €45M |
| Vivet Therapeutics | France | 1 | €38M |
| Sanifit | Spain | 1 | €37M |
| Medlumics | Spain | 1 | €34M |
| OxThera | Sweden | 1 | €32M |
| STAT-Diagnostica | Spain | 2 | €27M |
| Memo Therapeutics | Switzerland | 1 | €20M |
| BioVex | UK | 1 | €20M |
| Corwave | France | 1 | €16M |
| AM-Pharma | Netherlands | 1 | €12M |
| Inbiomotion | Spain | 1 | €2.1M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| SpliceBio | Series B | €118M | 2025-06 |
| Galecto Biotech | Series C | €79M | 2018-10 |
| Sparingvision | Series B | €75M | 2022-09 |
| Ona Therapeutics | Series B | €74M | 2026-06 |
| Northsea Therapeutics | Other | €71M | 2021-12 |
| ReproNovo | Series A | €57M | 2025-05 |
| Minoryx Therapeutics | Series C | €51M | 2022-05 |
| SpliceBio | Series A | €50M | 2022-02 |
| Xeltis | Series C | €45M | 2017-04 |
| Vivet Therapeutics | Series A | €38M | 2017-05 |